Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Pharmacological and anatomical evidence suggests that abnormal glutamate neurotransmission may be associated with the pathophysiology of schizophrenia and mood disorders. Medial temporal lobe structural alterations have been implicated in schizophrenia and to a lesser extent in mood disorders. To comprehensively examine the ionotropic glutamate receptors in these illnesses, we used in situ hybridization to determine transcript expression of N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and kainate receptor subunits in the medial temporal lobe of subjects with schizophrenia, bipolar disorder (BD), or major depression (MDD). We used receptor autoradiography to assess changes in glutamate receptor binding in the same subjects. Our results indicate that there are region- and disorder-specific abnormalities in the expression of ionotropic glutamate receptor subunits in schizophrenia and mood disorders. We did not find any changes in transcript expression in the hippocampus. In the entorhinal cortex, most changes in glutamate receptor expression were associated with BD, with decreased GluR2, GluR3, and GluR6 mRNA expression. In the perirhinal cortex we detected decreased expression of GluR5 in all three diagnoses, of GluR1, GluR3, NR2B in both BD and MDD, and decreased NR1 and NR2A in BD and MDD, respectively. Receptor binding showed NMDA receptor subsites particularly affected in the hippocampus, where MK801 binding was reduced in schiz…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In depressed patients, synaptic plasticity pathways have been shown to be disrupted in the PFC and hippocampi, correlated with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and NMDA receptor abnormalities [45,46].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [45]
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 2×
“Neurotransmission mediated by ionotropic glutamate receptors underlies several forms of synaptic plasticity in the hippocampus, including long-term potentiation (LTP) and depression (LTD) (Bliss and Collingridge, 1993; Isaac et al, 1995; Linden and Connor, 1995; Nicoll and Malenka, 1995; Selig et al, 1995; Bear and Ab…”
BackgroundLOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONS
Scoville, W. B., & Milner, B. (1957) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.20.1.11 · Cited by 7,322
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 2×
“Scale bar: 5 mm. Neuropsychopharmacology containing predominantly NR2B to containing NR2A in response to different stimuli (Monyer et al, 1994; Sheng et al, 1994).”
BackgroundThe Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282 · cited 1×
“The entorhinal cortex is a crucial component of the medial temporal lobe memory system (Scoville and Milner, 1957; Squire and Zola-Morgan, 1991).”
BackgroundLong-Term Potentiation--A Decade of Progress?
Malenka, R. C., & Nicoll, A. R. A. (1999) · Science · doi:10.1126/science.285.5435.1870 · Cited by 2,729
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
Evidence for silent synapses: Implications for the expression of LTP
Isaac, J. T. R., Nicoll, R. A., & Malenka, R. C. (1995) · Neuron · doi:10.1016/0896-6273(95)90046-2 · Cited by 1,233
Modulation of Neuronal Migration by NMDA Receptors
Komuro, H., & Rakic, P. (1993) · Science · doi:10.1126/science.8096653 · Cited by 1,041
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit
Sakimura, K., Kutsuwada, T., Ito, I., Manabe, T., Takayama, C., Kushiya, E., Yagi, T., Aizawa, S., Inoue, Y., Sugiyama, H., et al. (1995) · Nature · doi:10.1038/373151a0 · Cited by 859
Contrasting properties of two forms of long-term potentiation in the hippocampus
Nicoll, R. A., & Malenka, R. C. (1995) · Nature · doi:10.1038/377115a0 · Cited by 854
Lawrie, S. M., & Abukmeil, S. S. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.2.110 · Cited by 843
Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riordan, H. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.5.433 · Cited by 759
Huettner, J. E., & Bean, B. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1307 · Cited by 751
Ransom, R. W., & Stec, N. L. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01818.x · Cited by 750
Interaction with the NMDA receptor locks CaMKII in an active conformation
Bayer, K.-U., De Koninck, P., Leonard, A. S., Hell, J. W., & Schulman, H. (2001) · Nature · doi:10.1038/35081080 · Cited by 732 · cited 1×
“Biochemical studies have shown highaffinity binding between the catalytic domain of CaMKII and the C-tail of NR2B subunit of the NMDA receptor (Strack and Colbran, 1998; Leonard et al, 1999; Strack et al, 2000; Bayer et al, 2001; Mayadevi et al, 2002).”
BackgroundNMDA Receptor Subunit Composition Controls Synaptic Plasticity by Regulating Binding to CaMKII
Barria, A., & Malinow, R. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.034 · Cited by 709 · cited 6×
“Studies of activation of CaMKII and trafficking of AMPA receptors in the hippocampus in MDD would be needed to support that hypothesis.”
BackgroundInfluentialLong-Term Depression in Hippocampus
Bear, M. F., & Abraham, W. C. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.002253 · Cited by 601
Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo
Quinlan, E. M., Philpot, B. D., Huganir, R. L., & Bear, M. F. (1999) · Nature Neuroscience · doi:10.1038/7263 · Cited by 573
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568 · cited 2×
“Positive modulators of the AMPA receptor, called ampakines, improve cognitive function in schizophrenia, whereas enhancement of AMPA receptormediated currents by these compounds may potentiate the activity of antipsychotic medications (Coyle, 1996).”
BackgroundTamminga, C. A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070016003 · Cited by 547
Maturation of a Central Glutamatergic Synapse
Wu, G.-Y., Malinow, R., & Cline, H. T. (1996) · Science · doi:10.1126/science.274.5289.972 · Cited by 546 · cited 1×
“…in the hippocampus, including long-term potentiation (LTP) and depression (LTD) (Bliss and Collingridge, 1993; Isaac et al, 1995; Linden and Connor, 1995; Nicoll and Malenka, 1995; Selig et al, 1995; Bear and Abraham, 1996; Wu et al, 1996; Bear and Rittenhouse, 1999; Malenka and Nicoll, 1999).”
BackgroundBogerts, B., Ashtari, M., Degreef, G., Alvir, J. M. J., Bilder, R. M., & Lieberman, J. A. (1990) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(90)90004-p · Cited by 544
The Stanley Foundation brain collection and Neuropathology Consortium
Torrey, E. F., Webster, M., Knable, M., Johnston, N., & Yolken, R. H. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00192-9 · Cited by 533
Subunit-Specific NMDA Receptor Trafficking to Synapses
Barria, A., & Malinow, R. (2002) · Neuron · doi:10.1016/s0896-6273(02)00776-6 · Cited by 515 · cited 1×
“This change can be driven by activity (Barria and Malinow, 2002), experience (Quinlan et al, 1999; Philpot et al, 2001; Mierau et al, 2004), or learning (Quinlan et al, 2004).”
BackgroundLinden, D. J., & Connor, J. A. (1995) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.18.030195.001535 · Cited by 510
Kim, M. J., Dunah, A. W., Wang, Y. T., & Sheng, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.031 · Cited by 494 · cited 1×
“In mature animals, some brain regions (eg, the hippocampus) contain predominantly NR2A, and both NR2A and NR2B NMDA receptor subunits play important roles in LTP (Sakimura et al, 1995; Ito et al, 1996; Kim et al, 2005).”
BackgroundA reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470
Insausti, R., Herrero, M. T., & Witter, M. P. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1997)7:2<146::aid-hipo4>3.0.co;2-l · Cited by 447
Different Contributions of the Hippocampus and Perirhinal Cortex to Recognition Memory
Wan, H., Aggleton, J. P., & Brown, M. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-03-01142.1999 · Cited by 447
Strack, S., & Colbran, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.20689 · Cited by 443
Sucher, N., Akbarian, S., Chi, C., Leclerc, C., Awobuluyi, M., Deitcher, D., Wu, M., Yuan, J., Jones, E., & Lipton, S. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06509.1995 · Cited by 420
Knable, M. B., Barci, B. M., Webster, M. J., Meador-Woodruff, J., & Torrey, E. F. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001471 · Cited by 407
Self-citationLeonard, A. S., Lim, I. A., Hemsworth, D. E., Horne, M. C., & Hell, J. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3239 · Cited by 385
Gao, X.-M., Sakai, K., Roberts, R. C., Conley, R. R., Dean, B., & Tamminga, C. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1141 · Cited by 372
Strack, S., McNeill, R. B., & Colbran, R. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001471200 · Cited by 356
Velakoulis, D., Pantelis, C., McGorry, P. D., Dudgeon, P., Brewer, W., Cook, M., Desmond, P., Bridle, N., Tierney, P., Murrie, V., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.133 · Cited by 354
Magnetic resonance imaging of brain in people at high risk of developing schizophrenia
Lawrie, S. M., Whalley, H., Kestelman, J. N., Abukmeil, S. S., Byrne, M., Hodges, A., Rimmington, J. E., Best, J. J., Owens, D. G., & Johnstone, E. C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06244-8 · Cited by 351
Cell biology of the hippocampal formation in schizophrenia
Weinberger, D. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00331-x · Cited by 321
Glutamate Acting at NMDA Receptors Stimulates Embryonic Cortical Neuronal Migration
Behar, T. N., Scott, C. A., Greene, C. L., Wen, X., Smith, S. V., Maric, D., Liu, Q.-Y., Colton, C. A., & Barker, J. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04449.1999 · Cited by 305
Nowak, G., Ordway, G. A., & Paul, I. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00057-w · Cited by 262
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1554 · Cited by 259
THE LEFT MEDIAL TEMPORAL REGION AND SCHIZOPHRENIA: A PET STUDY
FRISTON, K. J., LIDDLE, P. F., FRITH, C. D., HIRSCH, S. R., & FRACKOWIAK, R. S. J. (1992) · Brain · doi:10.1093/brain/115.2.367 · Cited by 259
Hashimoto, R., Takei, N., Shimazu, K., Christ, L., Lu, B., & Chuang, D.-M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00217-4 · Cited by 257
Probing the human hippocampus using rCBF: Contrasts in schizophrenia
Medoff, D. R., Holcomb, H. H., Lahti, A. C., & Tamminga, C. A. (2001) · Hippocampus · doi:10.1002/hipo.1070 · Cited by 257
Neuroprotective effects of lithium in cultured cells and animal models of diseases
Chuang, D., Chen, R., Chalecka‐Franaszek, E., Ren, M., Hashimoto, R., Senatorov, V., Kanai, H., Hough, C., Hiroi, T., & Leeds, P. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01179.x · Cited by 248
Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
Harrison, P. J., McLaughlin, D., & Kerwin, R. W. (1991) · The Lancet · doi:10.1016/0140-6736(91)93392-m · Cited by 238
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.41 · Cited by 234
Hippocampal neurons in schizophrenia
Heckers, S., & Konradi, C. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200073 · Cited by 233
Ibrahim, H. M., Hogg, A. J., Healy, D. J., Haroutunian, V., Davis, K. L., & Meador-Woodruff, J. H. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1811 · Cited by 233
Self-citationBogerts, B., Falkai, P., Haupts, M., Greve, B., Ernst, S., Tapernon-Franz, U., & Heinzmann, U. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90013-w · Cited by 227
Hippocampal Deformities in Schizophrenia Characterized by High Dimensional Brain Mapping
Csernansky, J. G., Wang, L., Jones, D., Rastogi-Cruz, D., Posener, J. A., Heydebrand, G., Miller, J. P., & Miller, M. I. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2000 · Cited by 227
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
Law, A. J., & Deakin, J. F. W. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00043 · Cited by 227
Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia
Harrison, P. J., & Eastwood, S. L. (2001) · Hippocampus · doi:10.1002/hipo.1067 · Cited by 223
Kristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001844 · Cited by 220
Self-citationThe anatomy, physiology and functions of the perirhinal cortex
Suzuki, W. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80071-7 · Cited by 211
Sills, M. A., Fagg, G., Pozza, M., Angst, C., Brundish, D. E., Hurt, S. D., Jay Wilusz, E., & Williams, M. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90063-v · Cited by 210
Eastwood, S. L., McDonald, B., Burnet, P. W. J., Beckwith, J. P., Kerwin, R. W., & Harrison, P. J. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00247-c · Cited by 207
Rempel-Clower, N. L. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.9.851 · Cited by 203
Stefanacci, L., SUZUKI, W. A., & Amaral, D. G. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961125)375:4<552::aid-cne2>3.0.co;2-0 · Cited by 202
Cell pathology in bipolar disorder
Rajkowska, G. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01149.x · Cited by 201
Bertolino, A., Callicott, J. H., Elman, I., Mattay, V. S., Tedeschi, G., Frank, J. A., Breier, A., & Weinberger, D. R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00555-6 · Cited by 198
Adler, C. M., Holland, S. K., Schmithorst, V., Tuchfarber, M. J., & M Strakowski, S. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00117.x · Cited by 194
Dracheva, S., Marras, S. A. E., Elhakem, S. L., Kramer, F. R., Davis, K. L., & Haroutunian, V. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1400 · Cited by 190
Jay, T. M., Thierry, A., Wiklund, L., & Glowinski, J. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00154.x · Cited by 187 · cited 2×
“Disinhibitory activation of CA1 pyramidal cells can be produced by inhibition of tonic GABA inputs by NMDA antagonists like PCP (Gurguis et al, 1990; Jay et al, 1992).”
BackgroundLynch, D. R., Anegawa, N. J., Verdoorn, T., & Pritchett, D. B. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10028-x · Cited by 173
Boyer, P., Skolnick, P., & Fossom, L. H. (1998) · Journal of Molecular Neuroscience · doi:10.1007/bf02761776 · Cited by 171
Evidence for altered trisynaptic circuitry in schizophrenic hippocampus
Benes, F. M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00136-5 · Cited by 170
A Molecular Mechanism for Stabilization of Learning-Induced Synaptic Modifications
Quinlan, E. M., Lebel, D., Brosh, I., & Barkai, E. (2004) · Neuron · doi:10.1016/s0896-6273(03)00874-2 · Cited by 161
Independent mechanisms for long-term depression of AMPA and NMDA responses
Selig, D. K., Hjelmstad, G. O., Herron, C., Nicoll, R. A., & Malenka, R. C. (1995) · Neuron · doi:10.1016/0896-6273(95)90045-4 · Cited by 158
Porter, R. H. P., Eastwood, S. L., & Harrison, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01404-7 · Cited by 158
Connections of the parahippocampal cortex. I. Cortical afferents
Room, P., & Groenewegen, H. J. (1986) · Journal of Comparative Neurology · doi:10.1002/cne.902510402 · Cited by 152
Takahata, R., & Moghaddam, B. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300127 · Cited by 150
A Kainate Receptor Increases the Efficacy of GABAergic Synapses
Jiang, L., Xu, J., Nedergaard, M., & Kang, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00298-7 · Cited by 143
Miller, J. A. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90687-o · Cited by 142
Cell pathology in mood disorders
Rajkowska, G. (2002) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2002.35228 · Cited by 135 · cited 1×
“…in neuronal size, density, and localization in the hippocampus in schizophrenia and BD, and to a lesser extent in major depressive disorder (MDD) (Arnold, 1997; Benes et al, 1998, 1999; Harrison, 1999; Weinberger, 1999; Harrison and Eastwood, 2001; Heckers and Konradi, 2002; Rajkowska, 2002a, b).”
BackgroundSiegel, S., Janssen, W., Tullai, J., Rogers, S., Moran, T., Heinemann, S., & Morrison, J. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-04-02707.1995 · Cited by 128
Suzuki, Y., Jodo, E., Takeuchi, S., Niwa, S., & Kayama, Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00298-1 · Cited by 126
Heresco-Levy, U., & Javitt, D. C. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00050-3 · Cited by 121
Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder
Scarr, E., Pavey, G., Sundram, S., MacKinnon, A., & Dean, B. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00024.x · Cited by 120
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00195-7 · Cited by 107
Acute versus chronic NMDA receptor blockade and synaptic AMPA receptor delivery
Zhu, J., & Malinow, R. (2002) · Nature Neuroscience · doi:10.1038/nn0602-850 · Cited by 106
Maier, M., Ron, M. A., Barker, G. J., & Tofts, P. S. (1995) · Psychological Medicine · doi:10.1017/s0033291700033171 · Cited by 102
Molecular basis for induction of ocular dominance plasticity
Bear, M. F., & Rittenhouse, C. D. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199910)41:1<83::aid-neu11>3.0.co;2-z · Cited by 101
Philpot, B. D., Weisberg, M. P., Ramos, M. S., Sawtell, N. B., Tang, Y., Tsien, J. Z., & Bear, M. F. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00136-8 · Cited by 96
EM colocalization of AMPA and NMDA receptor subunits at synapses in rat cerebral cortex
Kharazia, V., Phend, K. D., Rustioni, A., & Weinberg, R. J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12658-6 · Cited by 91
Deutch, A. Y., Öngür, D., & Duman, R. S. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00571-l · Cited by 87
AMPA Receptor Trafficking: A Road Map for Synaptic Plasticity
Esteban, J. A. (2003) · Molecular Interventions · doi:10.1124/mi.3.7.375 · Cited by 85
Healy, D. J., Haroutunian, V. H., Powchik, P., Davidson, M., Davis, K. L., Watson, S. J., & Meador‐Woodruff, J. H. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00014-1 · Cited by 82
Self-citationA volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia
Joyal, C. C., Laakso, M. P., Tiihonen, J., Syvälahti, E. K. G., Vilkman, H., Laakso, A., Alakare, B., Räkköläinen, V., Salokangas, R. K. R., & Hietala, J. A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01368-3 · Cited by 82
Single photon emission computed tomography in phencyclidine and related drug abuse
Hertzmann, M., Reba, R. C., & Kotlyarov, E. V. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.255b · Cited by 80
Cortical Glutamatergic Markers in Schizophrenia
Scarr, E., Beneyto, M., Meador‐Woodruff, J. H., & Dean, B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300758 · Cited by 69
Self-citationMierau, S. B., Meredith, R. M., Upton, A. L., & Paulsen, O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402916101 · Cited by 67
Further characterization of [3H]ifenprodil binding in rat brain
Hashimoto, K., Mantione, C. R., Spada, M. R., Neumeyer, J. L., & London, E. D. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90211-9 · Cited by 66
Baron, B. M., Siegel, B. W., Harrison, B. L., Gross, R. S., Hawes, C. R., & Towers, P. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20937-5 · Cited by 65
The medial temporal lobe in schizophrenia
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.460 · Cited by 64
Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia
Deicken, R. F., Pegues, M., & Amend, D. L. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00173-x · Cited by 61
Mayadevi, M., Praseeda, M., Kumar, K. S., & Omkumar, R. V. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s0167-4838(02)00315-1 · Cited by 61
Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex
Ułas, J., Nguyen, L., & Cotman, C. W. (1993) · Neuroreport · doi:10.1097/00001756-199308000-00014 · Cited by 57
The thalamus as a site of action of antipsychotic drugs
Cohen, B. M., & Wan, W. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.104 · Cited by 48
Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims.
Nowak, G., Szewczyk, B., Sadlik, K., Piekoszewski, W., Trela, F., Florek, E., & Pilc, A. (2003) · PubMed · Cited by 44
Ibrahim, H. M., Healy, D. J., Hogg, A. J., & Meador‐Woodruff, J. H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00072-3 · Cited by 42
Self-citationIonotropic Glutamate Receptor Modulation of 5-HT6 and 5-HT7 mRNA Expression in Rat Brain
Healy, D. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00043-3 · Cited by 41
Age-dependent reduction of hippocampal LTP in mice lacking N-methyl-d-aspartate receptor ϵ1 subunit
Ito, I., Sakimura, K., Mishina, M., & Sugiyama, H. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12258-3 · Cited by 40
Knable, M. B., Barci, B. M., Webster, M. J., Meador‐Woodruff, J. H., & Torrey, Ε. F. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001527 · Cited by 40
Self-citationPatterns of Regulation from mRNA and Protein Time Series
You, L., & Yin, J. (2000) · Metabolic Engineering · doi:10.1006/mben.1999.0139 · Cited by 39
Binding of the radiolabeled glycine site antagonist [3H]MDL 105,519 to homomeric NMDA-NR1a receptors
Siegel, B. W., Sreekrishna, K., & Baron, B. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00477-3 · Cited by 32
Jodo, E., Suzuki, Y., Takeuchi, S., Niwa, S., & Kayama, Y. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03967-7 · Cited by 28
Multiplicity of depressive episodes: Phenomenological and neuroendocrine correlates
Gurguis, G. N. M., Meador‐Woodruff, J. H., Haskett, R. F., & Greden, J. F. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90052-4 · Cited by 23
Self-citationZylberman, I., Sircar, R., Wong, M., Frusciante, M. J., Javitt, D. C., & Zukin, S. R. (1991) · Brain Research · doi:10.1016/0006-8993(91)91606-2 · Cited by 14
CGP 39653 binding in the chick CNS after NMDA receptor antagonist treatment
White, B. H., & Vogel, M. W. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271185 · Cited by 8
Cited by
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Gonzalez-Burgos, G., & Lewis, D. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn070 · Cited by 577
Feyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.005 · Cited by 421
NMDA Receptor and Schizophrenia: A Brief History
Coyle, J. T. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs076 · Cited by 410
Lasky‐Su, J., Neale, B. M., Franke, B., Anney, R. J. L., Zhou, K., Maller, J. B., Vasquez, A. A., Chen, W., Asherson, P., Buitelaar, J., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30867 · Cited by 391
Metadata
- Authors
- Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H.
- Affiliations
- University of Alabama at Birmingham (US)
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-14
- Volume
- 32
- Issue
- 9
- Pages
- 1888-1902
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2024278554
- Cited by
- 408
- References
- 115
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 32 · 2021: 26 · 2020: 22 · 2019: 19 · 2018: 10 · 2017: 13 · 2016: 18 · 2015: 32 · 2014: 23 · 2013: 25 · 2012: 28
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute
- National Institute of Mental Health (MH 53327, R01MH053327)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- glutamate receptors, schizophrenia, bipolar disorder, major depressive disorder, mood disorders, medial temporal lobe, entorhinal cortex, perirhinal cortex, hippocampus, NMDA receptor, AMPA receptors, kainate receptors, receptor binding, glutamatergic neurotransmission, synaptic transmission
- MeSH terms
- Adult, Analysis of Variance, Autoradiography, Female, Gene Expression Regulation, Humans, Indoles, Male, Middle Aged, Postmortem Changes, Protein Binding, Schizophrenia, Temporal Lobe, 2-Amino-5-phosphonovalerate, In Situ Hybridization, Receptors, Glutamate, Excitatory Amino Acid Antagonists, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.